John Todaro joined Needham & Company in 2021 to cover the Crypto asset and Blockchain sector. John joined Needham from TradeBlock, a crypto asset research, indexes, and analytics provider, where he was the Director of Research & Markets managing a team that conducted, analyzed, and distributed blockchain and crypto asset research. Prior to TradeBlock, he […]

David Saxon joined Needham & Company in 2017 covering medical technologies. Prior to joining Needham, David worked in asset management at firms including Merrill Lynch and Baker Avenue Asset Management. David holds an MBA from Boston University’s Questrom School of Business and a BA in Economics from Boston University. David is a CFA charterholder.

Kyle Peterson joined Needham & Company in 2018 covering the financial technology sector and currently focuses on the financial data and information space. Previously, Kyle was an equity research associate at FBR Capital Markets covering regional banks and online lenders. Prior to FBR, he served as an analyst for The McLean Group, a boutique investment […]

Bernie McTernan joined Needham & Company in 2021 as a Senior Research Analyst based in NYC covering the Internet & Consumer Technology sector. Bernie has well over a decade of equity research experience on the sell and buyside. Most recently Bernie was a Senior Analyst at Rosenblatt Securities, prior to that he worked as an […]

Ami Fadia joined Needham and Company in May 2021 covering Biotechnology with a focus on targeted oncology and neuroscience. Prior to joining Needham, Ami spent four years as a Managing Director and Senior Analyst at SVB Leerink and previous to that spent six years at UBS where she most recently held the position of Senior […]

Ryan Koontz joined Needham & Company in 2021 as a Senior Research Analyst, where he leads equity research for the Communications and Networking sectors, including Broadband, Optical, Data Center, Enterprise, and Space. With a coverage portfolio of over two dozen companies, Ryan brings a unique “full-stack” perspective to his widely-recognized research and analysis. Prior to […]

Gil Blum, Ph.D., joined Needham & Company’s Biotech research team in August 2017. Gil joined Needham from Cadwalader Wickersham & Taft, New York oldest law firm where he was a Scientific Advisor in intellectual property law and prosecution. Prior to Cadwalader, Gil held a postdoctoral fellowship at the Memorial-Sloan Kettering Cancer Center, developing early drug […]

Mike Cikos joined Needham & Company in 2019 and covers the Infrastructure & Analytics and Security Technology sectors. Prior to joining Needham, he served on the investment teams for buy-side organizations Systematic Financial Management and RS Investments, covering software. His previous sell-side experience includes roles as senior equity analyst at Macquarie and equity research analyst […]

Joseph Stringer joined Needham & Company in 2017, where he covers biotechnology companies. Prior to Needham, Joseph worked as a research scientist at Ra Pharmaceuticals. He conducted postdoctoral work at Yale University, earned his Ph.D. in Chemistry from the University of Wisconsin – Madison, and received a B.S. in Chemistry from Southern Illinois University – […]

Chris Pierce joined Needham & Company, LLC in 2020 as a research analyst covering Internet Services, transitioning from an equity trading background. He also covers Transportation Technology. Most recently, he spent four years Balyasny Asset Management trading TMT & HC out of their San Francisco office. Prior to that he spent 10 years as a […]